Because KRAS mutations act in the context of cooccurring mutations, such as p53 mutations in CRC, cells containing mutants of KRAS (KRASm), p53 (p53m), and BRAF (BRAFm) were used to investigate the OA-induced IL-8/NOX4 axis. This evidence concerns the gene KRAS and colorectal carcinoma.